NFKB1 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: In effect, in dysferlinopathy patients, damage-associated molecular patterns (DAMPs) are released from damaged muscle fibers, triggering inflammatory responses via activation of NF-κB [41].